Navigation Links
RNL BIO Co. Ltd. stellt IND-Antrag, um klinische Phase-II-Studie des RNL-JointStem gegen Arthrose in den Vereinigten Staaten einzuleiten
Date:5/3/2013

ssiv zu Lähmungen führt, in erster Linie den Knorpel befällt und mit Veränderungen des Knochens verbunden ist. Knorpel verfügt über eine eingeschränkte intrinsische Heil- und Regenerationsfähigkeit.

Mit dieser Studie

Aufgrund der steigenden Inzidenz degenerativer Arthritis, der alternden Bevölkerung und der ineffizienten Therapieoptionen sind neue Strategien zum Knorpelaufbau erforderlich. Der Markt für ein therapeutisch wirksames Produkt für diese Indikation ist Schätzungen zufolge sehr groß.

Informationen zu IND-Anträgen

Der IND-Antrag (Investigational New Drug) ist Teil eines Zulassungsverfahrens zur Durchführung klinischer Untersuchungen in den Vereinigten Staaten. Ein IND-Antrag ist immer dann erforderlich, wenn die Durchführung einer klinischen Untersuchung in den Vereinigten Staaten beabsichtigt wird. Ein IND-Antrag enthält Informationen über die Qualität, Herstellung und Kontrolle eines Arzneimittelkandidaten sowie Daten aus präklinischen Studien und Angaben bezüglich des beabsichtigten Einsatzzwecks. Eine grundsätzliche Nutzen-Risiko-Bewertung sowie kritische Analysen präklinischer Daten unter Berücksichtigung aller potenziellen Risiken und Vorteile der vorgeschlagenen Studie müssen ebenfalls Teil des IND-Antrags sein.

Informationen zu klinischen Phase-II-Studien

Studien an klinischen Interventionen auf Basis von Biologika, wozu auch autologe, aus menschlichem Fett gewonnene Stammzellen gehören, unterliegen strengsten Kontrollen des Center for Biologics Evaluation and Research (CBER) der FDA. Nachdem das CBER und das örtliche Institutional Review Board (IRB) den Arzneimittelkandidaten für akzeptabel befunden haben, besteht die FDA auf die Durchführung einer Reihe mehrstufiger klinischer Studien. In Phase I ste
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
2. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
3. Harvest Technologies Corporation erhält CE-Kennzeichnung für erweiterte klinische Indikation zur Behandlung nicht optionaler kritischer Extremitätenischämie
4. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
5. IDEV gibt Ergebnisse von Studie zur Revaskularisation mit Supera an echten Patienten (RESTORE) bekannt - Studie demonstriert positive klinische Ergebnisse bei schwerkranken Patienten mit langen Läsionen
6. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
7. MR Solutions bringt vollständige Reihe heliumfreier präklinischer Magnetresonanztomographen auf den Markt
8. Neuartige Krebsimmuntherapie für den Beginn klinischer Studien bereit
9. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
10. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
11. RNL BIO Co. Ltd. lämnar in IND-ansökan om att påbörja klinisk fas II-prövning av RNL-JointStem för artros i USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 According ... Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current Trends, ... MarketsandMarkets, the global Dental Equipment Market is expected to ... in 2014, growing at a CAGR of 5.7% ... market data tables and 61 figures spread through ...
(Date:8/27/2014)... Pulse Systems, Inc. , an industry-leading provider of ... Revenue Cycle Management (RCM) solutions , will reveal some ... vendors, at UBM Medica,s Practice Rx conference in ... A presenter at the May Practice Rx ... session encouraging practices to "Look before You Leap: Understanding Revenue ...
(Date:8/27/2014)... Aug. 27, 2014 Sihuan Pharmaceutical Holdings ... "Company"), a leading pharmaceutical company with the largest ... China,s prescription drug market, today announced ... its subsidiaries (collectively the "Group") for the six ... Financial HighlightsFor the Six months ended 30 ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7
... SAN DIEGO , July 29 Orexigen® Therapeutics, Inc. (Nasdaq: ... its second quarter ended June 30, 2010 financial results on ... followed by a live webcast and conference call at 5:00 p.m. Eastern ... Orexigen management will ...
... , EMERYVILLE, Calif. , July 29 Bionovo, Inc. ... from the European Medicines Agency (EMA) in order to advance Menerba, the ... in Europe . The guidance defines the clinical and regulatory pathway ... , , ...
Cached Medicine Technology:Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010 2Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 2Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe 3
(Date:8/28/2014)... Sarasota, FL (PRWEB) August 28, 2014 ... Harmonica that produces deep, resonant, meditative sounds that can ... musical talent is needed to use it – just ... Pulmonica always sounds soothing. , Here are some ... ,     Close your eyes, relax, and maintain ...
(Date:8/28/2014)... On September 1st, the National Pediculosis Association (NPA) ... goal is to help families and entire communities work ... without exposures to risky pesticides. The NPA and ... to pesticides should be limited as much as possible.” ... often trivialized in the media, which present only a ...
(Date:8/27/2014)... PA (PRWEB) August 28, 2014 Author ... by iUniverse) takes readers on the thrilling adventures of ... book, published in 2012, is gearing up for a ... , Split into two novellas , “Prescription: Murder” ... surgeon who finds himself dodging assassination attempts and thwarting ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Spine Guide ... online source of information on spinal health. Now, the ... pain, or people suffering from back pain symptoms. Spine ... surgery, cervical/neck surgery, and lumbar spine surgery. , Some ... ache, shooting or stabbing pain, pain radiating down the ...
(Date:8/27/2014)... The National League for Nursing is pleased to ... became the inaugural director of the NLN/Chamberlain College ... of Nursing Education , effective August 11. The center ... for Transformative Excellence, established with the League’s historic move ... Under Dr. Dennis’s leadership, the NLN/Chamberlain Center will expand ...
Breaking Medicine News(10 mins):Health News:Ever Thought of Meditating With a Harmonica; Harmonica Techs, Inventors of the Pulmonica® Pulmonary Harmonica®, Present Tips on How to Relax with Soothing Sounds 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4
... , THURSDAY, May 17 (HealthDay News) -- Smoking ... and 2010, but too many of them still light up, ... current cigarette use among U.S. teens decreased from nearly 12 ... dropped from nearly 40 percent to about 34 percent among ...
... patients with one of the most common causes of blindness ... partnership. Researchers from the University of Strathclyde and Stanford ... of age related macular degeneration (AMD), which affects one in ... in eight aged over 85. The device would be ...
... Mental distractions can act as a form of pain relief, ... to complete a difficult or easy memory task while a ... participants perceived less pain when they were more distracted by ... MRI, the German researchers also found that the lower levels ...
... (May 16, 2012)If racial and ethnic disparities in breast cancer ... of imaging to assess the extent of tumors before surgery, ... Chase Cancer Center researchers at the 2012 Annual Meeting of ... "It,s encouraging that we didn,t see any differences between ...
... ALEXANDRIA, Va. The American Society of Clinical Oncology ... from among more than 4,500 abstracts publicly posted online ... Plenary, late-breaking and other major studies will be ... to be held June 1-5, 2012, at McCormick Place ...
... Macmillan Survivorship Research Group (MSRG), at the University of Southampton, ... the experiences and needs of people after primary treatment of ... people are living with, or beyond, cancer in the UK, ... average over 6,000 patients are diagnosed with cancer each year ...
Cached Medicine News:Health News:Fewer Young Americans Smoking, Survey Finds 2Health News:Prosthetic retina offers simple solution to restoring sight 2Health News:Prosthetic retina offers simple solution to restoring sight 3Health News:Fox Chase researchers find no disparities in imaging before breast cancer surgery 2Health News:ASCO releases studies from upcoming annual meeting 2Health News:Researchers undertake radical new cancer survivorship study 2Health News:Researchers undertake radical new cancer survivorship study 3
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
This chamber is designed to provide a large workspace and gloveless dexterity in closed environment industrial, research and development, quality control packaging applications. Atmospheres of nitrog...
... incorporates all the familiar and proven features of ... with the Ruskinn patented gas mixing system.The gas ... - 20% in 0.1% increments), carbon dioxide (0% ... - 10% in 1% increments) components of the ...
... anaerobic workstation shares the innovative ... Concept systems.Bugbox is the perfect ... and is an easy to ... Bugbox is perfect as a ...
Medicine Products: